Rhumbline Advisers Abbott Laboratories Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Abbott Laboratories stock. As of the latest transaction made, Rhumbline Advisers holds 3,209,458 shares of ABT stock, worth $368 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,209,458

Previous 3,304,251 2.87%

Holding current value

$368 Million

Previous $343 Million 6.57%

% of portfolio

0.34%

Previous 0.33%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $9.49 Million - $11.2 Million	-94,793 Reduced 2.87%	3,209,458 $366 Million
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $3.86 Million - $4.31 Million	38,362 Added 1.17%	3,304,251 $343 Million
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $586,698 - $647,982	5,357 Added 0.16%	3,265,889 $371 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $1.11 Million - $1.36 Million	-12,283 Reduced 0.38%	3,260,532 $359 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $1.39 Million - $1.67 Million	14,566 Added 0.45%	3,272,815 $317 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $2.98 Million - $3.33 Million	29,616 Added 0.92%	3,258,249 $355 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $3.11 Million - $3.66 Million	32,129 Added 1.01%	3,228,633 $327 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $10.4 Million - $12.2 Million	109,177 Added 3.54%	3,196,504 $351 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $8.27 Million - $9.58 Million	85,509 Added 2.85%	3,087,327 $299 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $8.89 Million - $10.7 Million	87,051 Added 2.99%	3,001,818 $326 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $23.5 Million - $28.6 Million	-205,905 Reduced 6.6%	2,914,767 $345 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $3.03 Million - $3.71 Million	26,209 Added 0.85%	3,120,672 $439 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $1.72 Million - $1.9 Million	-14,742 Reduced 0.47%	3,094,463 $366 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $10.7 Million - $12.6 Million	-101,351 Reduced 3.16%	3,109,205 $360 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $21.3 Million - $25.1 Million	-195,774 Reduced 5.75%	3,210,556 $385 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $1.8 Million - $1.96 Million	-17,127 Reduced 0.5%	3,406,330 $373 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $2.21 Million - $2.68 Million	-24,071 Reduced 0.7%	3,423,457 $373 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $7.6 Million - $9.73 Million	99,306 Added 2.97%	3,447,528 $315 Million
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $1.14 Million - $1.66 Million	18,071 Added 0.54%	3,348,222 $264 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $4.19 Million - $4.67 Million	53,419 Added 1.63%	3,330,151 $289 Million
Q3 2019 Oct 23, 2019	BUY	$81.84 - $88.74 $6.66 Million - $7.23 Million	81,438 Added 2.55%	3,276,732 $274 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $3.12 Million - $3.64 Million	42,866 Added 1.36%	3,195,294 $269 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $3.16 Million - $3.82 Million	-47,669 Reduced 1.49%	3,152,428 $252 Million
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $3.21 Million - $3.63 Million	48,900 Added 1.55%	3,200,097 $231 Million
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $1.43 Million - $1.72 Million	-23,446 Reduced 0.74%	3,151,197 $231 Million
Q2 2018 Aug 06, 2018	BUY	$57.57 - $63.54 $435,171 - $480,298	7,559 Added 0.24%	3,174,643 $194 Million
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $1.13 Million - $1.27 Million	20,012 Added 0.64%	3,167,084 $190 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $5.62 Million - $6.01 Million	104,627 Added 3.44%	3,147,072 $180 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $146 Million - $163 Million	3,042,445	3,042,445 $162 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Abbott Laboratories Transaction History